Congestion explains many of the signs and symptoms of acute heart failure (AHF) and
disease progression. However, accurate quantification of congestion is challenging in daily …

Objectives Soluble suppression of tumorigenicity 2 (sST2) is a member of the interleukin-1
receptor family. It is raised in various cardiovascular diseases, but its value in predicting …

Objectives The aim of this study was to evaluate the association between antigen
carbohydrate 125 (CA125) and the risk of 1-year clinical outcomes in patients with …

Introduction and objectives Carbohydrate antigen 125 (CA125) has been shown to be useful
for risk stratification in patients admitted with acute heart failure (AHF). We sought to …

Aim Vascular congestion may lead to an increase of carbohydrate antigen 125 (CA‐125).
The role of CA‐125 as a biomarker of congestion or for prognosis across the full ejection …

Aims In ambulatory patients with chronic heart failure (HF), congestion and decongestion
assessment may be challenging. The aim of this study is to assess the value of lung …

Aims A decrease in carbohydrate antigen 125 (CA‐125) predicts survival advantage in
chronic heart failure (HF); the impact of its variation in acute HF is unknown. We studied the …

The value of serum carbohydrate antigen 125 (CA125) combined with N-terminal pro-B-type
natriuretic peptide (NT-proBNP) in the evaluation of acute heart failure (AHF) after ST …

The pathophysiology of heart failure (HF) is complex with multiple pathways involved [1].
Biomarkers can help in diagnosing HF, estimating the risk of adverse events, monitoring HF …

Background In a previous study, the cardio-ankle vascular index (CAVI) was increased
significantly in idiopathic pulmonary arterial hypertension (IPAH) patients compared to the …